NewsBenzingaJP Morgan mantiene su recomendación de sobreponderar IDEAYA Biosciences y reduce su precio objetivo a 55 dólares JP Morgan mantiene su recomendación de sobreponderar IDEAYA Biosciences y reduce su precio objetivo a 55 dólares Benzinga 2026.11.20 18:01 (GMT+0) Open on Benzinga Other news UBS Maintains Buy on Keysight Techs, Lowers Price Target to $380 UBS Maintains Neutral on Intuit, Lowers Price Target to $315 Walmart Gets Bullish Rating Despite Pharmacy Deflation Headwinds Sky's USDC Exit Reserve Rises 29% to 1.13 Billion UBS Maintains Neutral on Ingredion, Lowers Price Target to $98 UBS Maintains Neutral on Hewlett Packard, Lowers Price Target to $52